South America Electrophysiology Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Electrophysiology Ablation Catheters, Electrophysiology Laboratory Devices, Electrophysiology Diagnostic Catheters, Access Devices, and Others) and Indication [Atrial Fibrillation (AF), Atrial Flutter, Wolff-Parkinson White Syndrome (WPW), Atrioventricular Nodal Reentry Tachycardia (AVNRT), and Others]

The SAM electrophysiology market is expected to grow from US$ 501.31 million in 2022 to US$ 853.82 million by 2028; it is estimated to grow at a CAGR of 9.3% from 2022 to 2028.

The geriatric population is prone to various ailments, such as abdominal discomfort and cardiovascular disease. The growing aging population base and the increasing prevalence of cardiac arrhythmia are a few of the major factors driving the electrophysiology market growth. Electrophysiological devices are used to diagnose these disorders in the geriatric population. According to the World Health Organization (WHO), the geriatric population worldwide will grow from ~1 billion in 2019 to ~2.1 billion by 2050. Therefore, market players are developing effective products to cater to the growing patient population that will benefit the electrophysiology market growth.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM electrophysiology market at a substantial CAGR during the forecast period.   

SAM Electrophysiology Market Revenue and Forecast to 2028 (US$ Million)

SAM Electrophysiology Market Segmentation   

The SAM electrophysiology market is segmented based on product, indication, and country. Based on product, the market is segmented into electrophysiology ablation catheters, electrophysiology laboratory devices, electrophysiology diagnostic catheters, access devices, and others. The electrophysiology laboratory devices segment dominated the market in 2022 and electrophysiology ablation catheters segment is expected to be fastest growing during forecast period. Based on indication, the market is segmented into atrial fibrillation (AF), atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), wolff-parkinson-white syndrome (WPW), and others. The atrial fibrillation (AF) segment dominated the market in 2022 and is expected to be fastest growing during forecast period. Based on country, the SAM electrophysiology market is segmented into Brazil, Argentina, and the Rest of SAM.     

Abbott; Biotronik, Inc.; Boston Scientific Corporation; CardioFocus; GE Healthcare; Johnson & Johnson Services, Inc.; Koninklijke Philips N.V.; Medtronic; MicroPort Scientific Corporation; and Siemens Healthineers AG are among the leading companies operating in the SAM electrophysiology market. 

1. Abbott
2. Biotronik, Inc.
3. Boston Scientific Corporation
4. CardioFocus
5. GE Healthcare
6. Johnson & Johnson Services, Inc.
7. Koninklijke Philips N.V.
8. Medtronic
9. MicroPort Scientific Corporation
10. Siemens Healthineers AG

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM electrophysiology market.       
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the SAM electrophysiology market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the electrophysiology market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution